CVE-2023-40153
Dexma Dexgate vulnerability
The affected product is vulnerable to a cross-site scripting vulnerability, which could allow an attacker to access the web application to introduce arbitrary Java Script by injecting an XSS payload into the 'hostname' parameter of the vulnerable software.
Affected products
Dexgate. The exact versions are in the references.
What to do now
- Check your exposureFind out whether Dexma Dexgate runs anywhere in your environment, including systems of suppliers.
- UpdateInstall the version in which the vendor fixed the vulnerability. The references lead to the advisory.
- Set the orderSystems that can be reached from the internet come first, then the rest.
References
Data: CVE list and the NVD. This product uses data from the NVD API but is not endorsed or certified by the NVD.